Atlas FDA

Surpass Elite Flow Diverter System

FDA premarket approval P170024/S018 · decided 2024-10-16

Approval details

PMA number
P170024
Supplement
S018
Supplement type
Real-Time Process
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
Surpass Elite Flow Diverter System
Generic name
Intracranial aneurysm flow diverter
Applicant
Stryker Neurovascular
Date received
2024-07-19
Decision date
2024-10-16
Days to decision
89 days
Decision code
APPR
Product code
OUT
Advisory committee
Neurology
Expedited review
No
Location
Fremont, CA
Statement
approval for the following claim for the Surpass Elite Flow Diverter System for use in marketing materials: “Due to a proprietary surface modification, the implant has reduced thrombin generation when compared to unmodified stents based on acute in-vitro tests. Data derived from the referenced studies and may not be representative of clinical performance.”

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Trevo Trak 21 Microcatheter (K261889)Stryker Neurovascular2026-07-01
AXS Lift Intracranial Base Catheter (K253032)Stryker Neurovascular2026-02-11
Target Detachable Coil (K252694)Stryker Neurovascular2025-12-11
InZone IST Detachment System; IZDS Connecting Cable (K251832)Stryker Neurovascular2025-10-17
Excelsior XT-27 Microcatheter, Excelsior XT-27 Flex Microcatheter, Excelsior XT-27 Pre-Shaped Microcatheter, Excelsior XT-27 Flex Pre-Shaped Microcatheter (K242289)Stryker Neurovascular2025-03-21
AXS Lift Intracranial Base Catheter (K243593)Stryker Neurovascular2025-02-18
Broadway 8 Catheter (K241768)Stryker Neurovascular2024-12-19
Echo Intracranial Base Catheter (K241637)Stryker Neurovascular2024-12-19